Carotid Artery Disease

Categories: Blood diseases, Cardiovascular diseases, Neuronal diseases

Aliases & Classifications for Carotid Artery Disease

MalaCards integrated aliases for Carotid Artery Disease:

Name: Carotid Artery Disease 12 42 15 62 17
Carotid Artery Diseases 54 43 71
Disorder of Carotid Artery 12


External Ids:

Disease Ontology 12 DOID:3407
MeSH 43 D002340
NCIt 49 C84476
SNOMED-CT 67 371160000
ICD10 32 G45.1
UMLS 71 C0007273

Summaries for Carotid Artery Disease

MedlinePlus : 42 Your carotid arteries are two large blood vessels in your neck. They supply your brain and head with blood. If you have carotid artery disease, the arteries become narrow or blocked, usually because of atherosclerosis. Atherosclerosis is the buildup of plaque, which is made up of fat, cholesterol, calcium, and other substances found in the blood. Carotid artery disease is serious because it can block the blood flow to your brain, causing a stroke. Too much plaque in the artery can cause a blockage. You can also have a blockage when a piece of plaque or a blood clot breaks off the wall of an artery. The plaque or clot can travel through the bloodstream and get stuck in one of your brain's smaller arteries. Carotid artery disease often does not cause symptoms until the blockage or narrowing is severe. One sign may be a bruit (whooshing sound) that your doctor hears when listening to your artery with a stethoscope. Another sign is a transient ischemic attack (TIA), a "mini-stroke." A TIA is like a stroke, but it only lasts a few minutes, and the symptoms usually go away within an hour. Stroke is another sign. Imaging tests can confirm whether you have carotid artery disease. Treatments may include Healthy lifestyle changes Medicines Carotid endarterectomy, surgery to remove the plaque Angioplasty, a procedure to place a balloon and stent into the artery to open it and hold it open NIH: National Heart, Lung, and Blood Institute

MalaCards based summary : Carotid Artery Disease, also known as carotid artery diseases, is related to stroke, ischemic and atherosclerosis susceptibility, and has symptoms including edema, chest pain and angina pectoris. An important gene associated with Carotid Artery Disease is SLC39A2 (Solute Carrier Family 39 Member 2), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Degradation of the extracellular matrix. The drugs Exenatide and Simvastatin have been mentioned in the context of this disorder. Affiliated tissues include heart, brain and testes, and related phenotypes are cardiovascular system and homeostasis/metabolism

PubMed Health : 62 About carotid artery disease: Carotid (ka-ROT-id) artery disease is a disease in which a waxy substance called plaque (plak) builds up inside the carotid arteries. You have two common carotid arteries, one on each side of your neck. They each divide into internal and external carotid arteries. The internal carotid arteries supply oxygen-rich blood to your brain. The external carotid arteries supply oxygen-rich blood to your face, scalp, and neck.

Related Diseases for Carotid Artery Disease

Diseases related to Carotid Artery Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 360)
# Related Disease Score Top Affiliating Genes
1 stroke, ischemic 32.2 THBD REN PLG MMP9 LPA CRP
2 atherosclerosis susceptibility 32.0 THBD SELE MMP9 LPA CRP COG2
3 amaurosis fugax 31.6 MMP9 MMP8
4 arteries, anomalies of 31.4 REN PLG MIR126 LPA CRP COG2
5 carotid stenosis 31.4 SELE REN MMP9 MMP1 LPA CRP
6 hyperlipoproteinemia, type iii 31.2 LPA APOE APOB APOA1
7 retinal artery occlusion 31.2 PLG CRP CCL2 ACE
8 vascular disease 31.1 TIMP1 THBD SELE REN PLG MMP9
9 intracranial embolism 30.9 PLG CRP ACE
10 hypercholesterolemia, familial, 1 30.7 LPA CRP COG2 APOE APOB APOA1
11 moyamoya disease 1 30.7 PLG MMP9 LPA
12 aortic aneurysm 30.6 TIMP1 MMP9 MMP3 CRP APOE ACE
13 chlamydia pneumonia 30.5 CRP CCL2 APOE
14 cerebrovascular disease 30.5 THBD SELE REN MMP9 LPA CRP
15 hypertriglyceridemia, familial 30.5 APOE APOB APOA1
16 hypertensive retinopathy 30.5 REN CRP ACE
17 peripheral artery disease 30.5 THBD CRP CCL2 APOE APOB APOA1
18 cardiac arrest 30.5 THBD SELE REN APOE ACE
19 heart valve disease 30.5 REN MIR126 LPA CRP ACE
20 renal hypertension 30.4 REN CRP ACE
21 hyperuricemia 30.4 REN CRP APOE APOB
22 atrial fibrillation 30.4 REN MIR126 CRP ACE
23 peripheral vascular disease 30.4 TIMP1 THBD SELE LPA CRP COG2
24 pulmonary edema 30.3 REN CRP ACE
25 coronary stenosis 30.3 CRP APOE APOB APOA1 ACE
26 end stage renal disease 30.3 THBD REN CRP ACE
27 microvascular complications of diabetes 1 30.3 TIMP1 MMP9 CCL2
28 vascular dementia 30.2 MMP9 CRP APOE APOA1 ACE
29 intracranial aneurysm 30.2 CCL2 APOE ACE
30 homocysteinemia 30.2 THBD LPA CRP CCL2 APOE
31 vasculitis 30.2 THBD SELE CRP CCL2
32 antiphospholipid syndrome 30.2 THBD SELE CRP
33 familial hypercholesterolemia 30.2 LPA CRP COG2 APOE APOB APOA1
34 non-alcoholic fatty liver disease 30.1 TIMP1 MIR126 CRP APOB APOA1
35 sleep apnea 30.1 SELE REN CRP CCL2 APOE APOB
36 takayasu arteritis 30.1 THBD SELE MMP9 MMP3 CRP
37 migraine with or without aura 1 30.1 REN PLG MMP9 CRP APOE ACE
38 lung disease 30.0 MMP9 MMP8 CRP CCL2 ACE
39 intermediate coronary syndrome 30.0 PLG MIR126 LPA CRP COG2 APOB
40 intracranial berry aneurysm 30.0 SELE REN PLG MMP9 CRP APOE
41 lipoprotein quantitative trait locus 30.0 SELE REN PLG MMP9 MIR126 LPA
42 generalized atherosclerosis 30.0 REN LPA CRP COG2 APOE APOB
43 lipid metabolism disorder 29.9 SELE MIR126 LPA CRP COG2 CCL2
44 aortic aneurysm, familial abdominal, 1 29.9 TIMP1 MMP9 MMP8 MMP3 MMP1 CRP
45 eye disease 29.8 MMP9 MMP1 MIR126 CRP CCL2 APOA1
46 kidney disease 29.7 THBD REN LPA CRP COG2 CCL2
47 chronic kidney disease 29.6 THBD REN MMP9 MMP3 LPA CRP
48 coronary heart disease 1 29.6 SELE MIR126 LPA CRP COG2 APOE
49 pulmonary disease, chronic obstructive 29.5 TIMP1 MMP9 MMP8 MMP1 MIR126 CRP
50 acute myocardial infarction 29.2 THBD SELE REN PLG MMP9 MIR126

Graphical network of the top 20 diseases related to Carotid Artery Disease:

Diseases related to Carotid Artery Disease

Symptoms & Phenotypes for Carotid Artery Disease

UMLS symptoms related to Carotid Artery Disease:

edema, chest pain, angina pectoris

MGI Mouse Phenotypes related to Carotid Artery Disease:

# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.1 ACE APOA1 APOB APOE CD163 CRP
2 homeostasis/metabolism MP:0005376 10.09 ACE APOA1 APOB APOE CD163 COG2
3 hematopoietic system MP:0005397 10 ACE APOE CD163 COG2 MMP3 MMP9
4 immune system MP:0005387 9.83 ACE APOB APOE CCL2 CD163 CRP
5 liver/biliary system MP:0005370 9.23 ACE APOA1 APOB APOE PLG SELE

Drugs & Therapeutics for Carotid Artery Disease

PubMed Health treatment related to Carotid Artery Disease: 62

Treatments for carotid artery disease may include lifestyle changes, medicines, and medical procedures. The goals of treatment are to stop the disease from getting worse and to prevent a stroke . Your treatment will depend on your symptoms, how severe the disease is, and your age and overall health.

Drugs for Carotid Artery Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 155)
# Name Status Phase Clinical Trials Cas Number PubChem Id
Exenatide Approved, Investigational Phase 4 141758-74-9 15991534
Simvastatin Approved Phase 4 79902-63-9 54454
Clopidogrel Approved Phase 4 113665-84-2, 120202-66-6 60606
Cilostazol Approved, Investigational Phase 4 73963-72-1 2754
Pioglitazone Approved, Investigational Phase 4 111025-46-8 4829
Metformin Approved Phase 4 657-24-9 14219 4091
Glyburide Approved Phase 4 10238-21-8 3488
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
Atorvastatin Approved Phase 4 134523-00-5 60823
Rivaroxaban Approved Phase 4 366789-02-8
Folic acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
Niacin Approved, Investigational, Nutraceutical Phase 4 59-67-6 938
13 Incretins Phase 4
14 Lipid Regulating Agents Phase 4
15 Hypolipidemic Agents Phase 4
16 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 4
17 Anticholesteremic Agents Phase 4
18 Antimetabolites Phase 4
19 Trace Elements Phase 4
20 Micronutrients Phase 4
21 Vitamins Phase 4
22 Nutrients Phase 4
23 Neurotransmitter Agents Phase 4
24 Purinergic P2Y Receptor Antagonists Phase 4
25 Respiratory System Agents Phase 4
26 Phosphodiesterase 3 Inhibitors Phase 4
27 Phosphodiesterase Inhibitors Phase 4
28 Neuroprotective Agents Phase 4
29 Anti-Asthmatic Agents Phase 4
30 Bronchodilator Agents Phase 4
31 Hypoglycemic Agents Phase 4
32 Rosuvastatin Calcium Phase 4 147098-20-2
33 Calcium, Dietary Phase 4
34 Insulin, Globin Zinc Phase 4
35 insulin Phase 4
36 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,... Phase 4
37 Sodium-Glucose Transporter 2 Inhibitors Phase 4
38 Vitamin B Complex Phase 4
39 Vitamin B3 Phase 4
40 Nicotinic Acids Phase 4
41 Colesevelam Hydrochloride Phase 4
42 Vasodilator Agents Phase 4
43 Folate Phase 4
44 Vitamin B9 Phase 4
45 Antithrombins Phase 4
46 Antithrombin III Phase 4
47 Serine Proteinase Inhibitors Phase 4
protease inhibitors Phase 4
49 Factor Xa Inhibitors Phase 4
50 HIV Protease Inhibitors Phase 4

Interventional clinical trials:

(show top 50) (show all 197)
# Name Status NCT ID Phase Drugs
1 Early Warning and Optimization Strategy in Carotid Endarterectomy Unknown status NCT01210937 Phase 4
2 A 2-year, Open-label, Randomized Study to Evaluate the Efficacy of Rosuvastatin Dosing Adjustment by LDL-C Level Compared to That of 5mg Maintenance Dose in Chinese Patients With Carotid Atherosclerotic Plaques Unknown status NCT02532309 Phase 4 Rosuvastatin (5mg,10mg,20mg);Rosuvastatin 5mg
3 Effect of Bydureon on Carotid Atherosclerosis Progression in T2DM Unknown status NCT02162550 Phase 4 Bydureon;placebo
4 Effects of Atorvastatin Treatment on Left Ventricular Diastolic Function in Peritoneal Dialysis Patients (ALEVENT) Unknown status NCT01503671 Phase 4 Atorvastatin
5 A Carotid Stenting Boston Scientific Surveillance Program Carotid WALLSTENT Monorail Endoprosthesis FilterWire EZ™ Embolic Protection System Completed NCT00741091 Phase 4
6 Emboshield and Xact Post Approval Carotid Stent Trial Using the Emboshield® BareWire™ Rapid Exchange Embolic Protection System and Xact® Rapid Exchange Carotid Stent System Completed NCT00287508 Phase 4
7 A Single Center IDE Study on Carotid Stenting With Distal Protection for the Treatment of Obstructive Carotid Artery Disease Completed NCT00178672 Phase 4
8 Effect of Cilostazol, a Phosphodiesterase 3 Inhibitor, on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes Completed NCT03248401 Phase 4 Cilostazol;Aspirin
9 Evaluation of the Effect of Atorvastatin and Pioglitazone in Carotid Atherosclerosis With the Use of 18Fluoride-Fludeoxyglucose(FDG) Positron Emission Tomography-computed Tomography (PET-CT)Imaging Completed NCT01341730 Phase 4 Atorvastatin 20mg;Atorvastatin 20 mg + Pioglitazone 30 mg
10 Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Carotid Intima Media Thickness and Its Relation to Plaque Components of the Coronary Arteries in Patients With ST-Segment Elevation Acute Myocardial Infarction Completed NCT01203982 Phase 4 Rosuvastatin;Rosuvastatin
11 A Randomised Placebo-controlled Trial of Metformin on Progression of Carotid Atherosclerosis in Non-diabetic Patients With Cardiovascular Disease Treated With Conventional Risk Reducing Agents Completed NCT00723307 Phase 4 Metformin;Placebo
12 Comparative Study of Dapagliflozin Versus Glibenclamide Effect on Endothelial Function of Coronary Artery Disease Patients Completed NCT02919345 Phase 4 Dapagliflozin 10 mg;Glibenclamide 5 mg
13 Stop Atherosclerosis in Native Diabetics Study Completed NCT00147251 Phase 4 FDA approved drugs to treat blood pressure and cholesterol
14 Does the Magnitude of Platelet Inhibition Inversely Correlate With the Number of TCD-detected Microemboli in Asymptomatic Patients Undergoing Carotid Artery Stenting Prior to Cardiac Surgery Who Are Being Pre-treated With 300 mg or 600 mg Loading Dose of Clopidogrel? Completed NCT01146301 Phase 4 Clopidogrel
15 Magnetic Resonance Characterization of Carotid Atherosclerotic Plaque in Vivo: Effect of High Density Lipoprotein Elevation on Plaque Morphology Completed NCT00307307 Phase 4 Niacin/simvastatin compared to simvastatin alone at 2 doses
16 Carotid Plaque Composition by Magnetic Resonance Imaging During Lipid Lowering Therapy Active, not recruiting NCT00715273 Phase 4 Atorvastatin;Niacin;Colesevelam;Placebo Niacin;Placebo Colesevelam
17 Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab - a Pilot Study Active, not recruiting NCT02992301 Phase 4 Alirocumab
18 DUAL Pathway Inhibition (Low-dose Rivaroxaban and Aspirin) as Compared to Aspirin Only to Improve Endothelial Function in Peripheral Artery Disease. Not yet recruiting NCT04218656 Phase 4 Rivaroxaban 2.5 Mg Oral Tablet
19 Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial Completed NCT00619775 Phase 3
20 Stenting and Angioplasty With Protection in Patients at High Risk for Endarterectomy Completed NCT00231270 Phase 3
21 Carotid With Bivalirudin Angioplasty Completed NCT00812383 Phase 2, Phase 3
22 Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS) Completed NCT00231231 Phase 3
24 Prospective, Non-Randomized, Multi-Center, Single-Arm Trial to Assess Safety & Efficacy of the Acculink Carotid Stent System With the Accunet Embolic Protection System in High-Risk Patients With Carotid Artery Lesions. Completed NCT00180518 Phase 2, Phase 3
25 Atherosclerosis Monitoring and Atherogenicity Reduction Study Completed NCT01734707 Phase 3 Placebo
26 The Effects of Lutein Supplementation on Subclinical Atherosclerosis Completed NCT01534533 Phase 2, Phase 3
27 A 72-week, Prospective, Parallel-group, Partially Blinded, Controlled Phase IIIb Study Evaluating the Impact of Specific Lp(a) Apheresis on Atherosclerotic Disease Burden in Coronary Heart Disease Patients With High Lipoprotein(a) Level. Completed NCT02133807 Phase 3
28 Cholesterol-Lowering Atherosclerosis Study (CLAS) Completed NCT00000599 Phase 3 colestipol;niacin
29 99m Tc-ANNexin-V-128 Scintigraphy for the Identification of Complicated Carotid Atherosclerotic Plaques Not yet recruiting NCT03630835 Phase 2, Phase 3
30 A Prospective, Randomized, Open-Label, Pilot Study To Compare The Effect On Carotid Atherosclerosis Of A Tacrolimus-Based Regimen With Conversion From A Tacrolimus- To A Sirolimus-Based Regimen At 3-4 Months Post-Transplant In De Novo Renal Transplant Recipients Terminated NCT00311311 Phase 3 tacrolimus;mycophenolate mofetil;prednisone;sirolimus;tacrolimus;mycophenolate mofetil;prednisone
31 Abciximab Versus Aspirin for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic >50% Carotid Stenosis: A Pilot Study (ASTERICS) Terminated NCT00126139 Phase 3 Abciximab
32 Double-blinded Placebo-controlled Multicenter Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis Unknown status NCT01743404 Phase 2 Placebo
33 Multimodal Assessment of the Inflammatory Atheromatous Plaque : Comparison Between 68Ga-NODAGA-RGD PET/CT, 18F-FDG PET/CT, MRI AND US Unknown status NCT01608516 Phase 1, Phase 2
34 A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis Completed NCT00851500 Phase 2 K-604
35 A Multi-centre, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Effect of the Lp-PLA2 Inhibitor SB-480848 (40, 80mg od) on Carotid Plaque Composition in Patients With Carotid Artery Disease and Planned Carotid Endarterectomy, Stratified for Statin Use and Gender, After 14+/-4 Days Treatment Completed NCT01916720 Phase 2 SB-480848 40 mg;SB-480848 80 mg;Placebo
36 A Randomized Clinical Trial to Evaluate the Effects of High Dose Statin and Niacin Therapy on Excised Plaque Biomarkers in Patients Undergoing Carotid Endarterectomy (CEA) Completed NCT00804843 Phase 2 Atorvastatin/niacin extended-release;Atorvastatin;Simvastatin;Simvastatin
37 Effect of Valsartan on Endothelial Function, Oxidative Stress, Carotid Atherosclerosis, and Endothelial Progenitor Cells (EFFERVESCENT) Completed NCT00208767 Phase 2 Valsartan;Placebo
38 Effect of High Dose Vitamin E on Carotid Atherosclerosis Completed NCT00010699 Phase 2 Vitamin E
39 Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With Carotid Atherosclerotic Plaques Not yet recruiting NCT03871725 Phase 1, Phase 2
40 Sonodynamic Therapy Manipulates Atherosclerosis Regression Trial on Patients With Carotid Atherosclerotic Plaques Not yet recruiting NCT03382249 Phase 1, Phase 2
41 Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation Not yet recruiting NCT02995642 Phase 2 18F-FPPRGD2
42 A Multi-Center, Open-Label, Dose-Finding, Feasibility Study of Optison in Contrast Enhanced U/S for the Detection of Carotid Artery Disease Terminated NCT01394926 Phase 2 Optison
43 An Exploratory, Phase II, Open Label, Single-Center, Non-Randomized Study Of [F-18] RGD-K5 Positron Emission Tomography (PET) In Participants With Carotid Artery Stenosis Terminated NCT01968226 Phase 2 [F-18] RDG-K5
44 Antioxidants and Prevention of Early Atherosclerosis Terminated NCT00000600 Phase 2 Vitamin E;Vitamin C
45 Carotid Artery Plaque Intravascular Ultrasound Evaluation Completed NCT00271076 Phase 1
46 Phase I Study to Evaluated the Safety of Noninvasive Molecular Imaging for the Detection of Inflammation in Carotid Atherosclerotic Lesions by Using Ga-68-NOTA-MSA in Healthy Volunteers and Patients With Coronary Artery Disease Completed NCT01893489 Phase 1
47 PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Carotid Atherosclerosis Completed NCT00547976 Phase 1 [C-11]PBR28
48 Cytokine and Leukocyte Activation Profile as a Risk Factor for Cerebral Vascular Disease and Stroke Completed NCT00001368 Phase 1
49 PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With [64]Cu-25%CANF-Comb Suspended NCT02417688 Phase 1
50 Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide) Unknown status NCT00403078

Search NIH Clinical Center for Carotid Artery Disease

Cochrane evidence based reviews: carotid artery diseases

Genetic Tests for Carotid Artery Disease

Anatomical Context for Carotid Artery Disease

MalaCards organs/tissues related to Carotid Artery Disease:

Heart, Brain, Testes, Endothelial, Lung, Kidney, Breast

Publications for Carotid Artery Disease

Articles related to Carotid Artery Disease:

(show top 50) (show all 2185)
# Title Authors PMID Year
Impact of early diagnosis of carotid artery stenosis by carotid ultrasound: A protocol of systematic review and meta-analysis. 42
32481359 2020
Carotid plaque magnetic resonance imaging and recurrent stroke risk: A systematic review and meta-analysis. 42
32221065 2020
Quantitative analysis of revascularization in ischemic moyamoya disease via whole-brain computed tomography perfusion: A retrospective single-center study. 42
32049846 2020
Association between human paraoxonase 1 activity and intima-media thickness in subjects under 55 years of age with carotid artery disease. 54 61
18073465 2008
TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease. 54 61
16474172 2006
The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status. 61 54
15995178 2005
Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease. 61 54
12805074 2003
Relationship of early carotid artery disease with lipoprotein (a), apolipoprotein B, and fibrinogen in asymptomatic essential hypertensive patients and normotensive subjects. 54 61
11730086 2001
Clinical features and prognosis of patients with spontaneous coronary artery dissection. 61
32245641 2020
Light-Induced Amaurosis-A Case Report and Brief Literature Review. 61
32027984 2020
Association of Plasma Marker of Oxidized Lipid with Histologic Plaque Instability in Patients with Peripheral Artery Disease. 61
31706994 2020
Evaluation of intracranial and extracranial atherosclerotic lesions in patients with symptomatic coronary artery disease. 61
32284016 2020
Concomitant transcarotid artery revascularization and transcatheter aortic valve replacement. 61
32322777 2020
Increased Serum CRP-Albumin Ratio Is Independently Associated With Severity of Carotid Artery Stenosis. 61
32527139 2020
Plasma Homocysteine in Patients with Coronary and Carotid Artery Disease: A Case Control Study. 61
32573476 2020
Shockwave intravascular lithoplasty for the treatment of calcified carotid artery stenosis: A very early single-center experience. 61
32383344 2020
The relationship between carotid disease and retinopathy in diabetes: a systematic review. 61
32375803 2020
Investigation of the Predictive Values of Triglyceride/HDL Cholesterol Ratio and Whole Blood Viscosity with Regard to Severe Peripheral or Carotid Artery Disease in Patients Scheduled for Coronary Bypass. 61
32524970 2020
Safety of carotid artery revascularization procedures in patients with atrial fibrillation. 61
32471737 2020
Preventing stroke in symptomatic carotid artery disease during the COVID-19 pandemic. 61
32448560 2020
Antithrombotic therapy in carotid artery disease. 61
32418521 2020
Safety of Triple Neuroprotection with targeted hypothermia, controlled induced hypertension and barbiturate infusion during emergency carotid endarterectomy for acute stroke after missing the 24 hours window opportunity. 61
32473308 2020
Concomitant ipsilateral carotid endarterectomy and stenting is an effective treatment for tandem carotid artery lesions. 61
31519511 2020
Cardiac allograft vasculopathy: Incidence and predictors in a single-center cohort. 61
32471665 2020
Does Resting Cardiac Power Index Affect Survival Post Transcatheter Aortic Valve Replacement? 61
32198316 2020
Presentation and outcomes of carotid endarterectomy in active smokers. 61
32249043 2020
Robotic assisted carotid artery stenting for the treatment of symptomatic carotid disease: technical feasibility and preliminary results. 61
32115435 2020
Midterm Results After Simultaneous Carotid Artery Stenting and Cardiac Surgery. 61
32247782 2020
A Systematic Review for the Design of In Vitro Flow Studies of the Carotid Artery Bifurcation. 61
31823191 2020
Paraoxonase-1 and Symptomatic Status in Carotid Artery Disease. 61
31626928 2020
Association between rs2107595 HDAC9 gene polymorphism and advanced carotid atherosclerosis in the Slovenian cohort. 61
32284067 2020
Left Common Carotid Artery Biomechanical Properties in Individuals over 80 years: Women Have Stiffer Vessels. 61
32173475 2020
Rivaroxaban plus aspirin for the prevention of ischaemic events in patients with cardiovascular disease: a cost-effectiveness study. 61
32223323 2020
Hyoid bone impingement contributing to symptomatic atherosclerosis of the carotid bifurcation. 61
32095663 2020
Anatomic criteria in the selection of treatment modality for atherosclerotic carotid artery disease. 61
32145991 2020
Contrast-enhanced ultrasound perfusion patterns and serum lipid signatures of vulnerable carotid artery plaque in predicting stroke: A cohort study of carotid stenosis in Chinese patients. 61
32039838 2020
Prediction of Stroke Risk by Detection of Hemorrhage in Carotid Plaques: Meta-Analysis of Individual Patient Data. 61
31202755 2020
Carotid Artery Stenting in Asymptomatic Carotid Artery Stenosis: JACC Review Topic of the Week. 61
32057380 2020
Ferumoxytol-enhanced three-dimensional magnetic resonance imaging of carotid atheroma- a feasibility and temporal dependence study. 61
32020031 2020
Large-scale network dysfunction in vascular cognitive disorder supports connectional diaschisis in advanced arteriosclerosis. 61
31505084 2020
Limb shaking transient ischemic attacks: A follow-up of 28 patients. 61
31916976 2020
Comparison of relative safety and efficacy of handmade S-shaped catheter and conventional catheters in concomitant carotid and coronary angiography. 61
31974327 2020
Endothelin-1 increases expression and activity of arginase 2 via ETB receptors and is co-expressed with arginase 2 in human atherosclerotic plaques. 61
31606133 2020
The structural properties of carotid arteries in carotid artery diseases - a retrospective computed tomography angiography study. 61
32467741 2020
Pulmonary Artery Acceleration Time in Young Adulthood and Cardiovascular Outcomes Later in Life: The Coronary Artery Risk Development in Young Adults Study. 61
31648849 2020
Arterial wall mechanical inhomogeneity detection and atherosclerotic plaque characterization using high frame rate pulse wave imaging in carotid artery disease patients in vivo. 61
31746784 2020
The potential relationship between 18F-FDG uptake and wall shear stress in a patient with carotid artery disease. 61
31970680 2020
The Association Between SYNTAX Score II and Carotid Artery Disease Severity in Patients Who Underwent Coronary Artery Bypass Grafting. 61
31416325 2020
The use of high-resolution MRI to detect thrombosis and lipid-rich carotid artery plaques in a patient with homozygous familial hypercholesterolemia. 61
32130378 2020
A Clinical Association between an Increasing Renal Resistive Index and the Atherosclerotic Burden in Patients with a Preserved Renal Function. 61
32238661 2020

Variations for Carotid Artery Disease

Copy number variations for Carotid Artery Disease from CNVD:

# CNVD ID Chromosome Start End Type Gene Symbol CNVD Disease
1 49065 11 102660640 102668966 Copy number MMP1 Carotid artery disease
2 49067 11 102706527 102714342 Copy number MMP3 Carotid artery disease
3 163976 22 33196801 33259027 Copy number TIMP3 Carotid artery disease
4 207773 6 160952515 161087407 Copy number LPA Carotid artery disease
5 207774 6 160952515 161087407 Copy number LPAL2 Carotid artery disease
6 207775 6 160952515 161087407 Copy number PLG Carotid artery disease

Expression for Carotid Artery Disease

Search GEO for disease gene expression data for Carotid Artery Disease.

Pathways for Carotid Artery Disease

Pathways related to Carotid Artery Disease according to GeneCards Suite gene sharing:

(show all 24)
# Super pathways Score Top Affiliating Genes
Show member pathways
Show member pathways
Show member pathways
12.25 MMP9 MMP3 MMP1 CCL2
Show member pathways
12.21 TIMP1 MMP3 MMP1 CCL2
Show member pathways
Show member pathways
Show member pathways
9 11.91 SELE MMP9 MMP3 CCL2
10 11.89 TIMP1 MMP9 MMP3 MMP1 CCL2
Show member pathways
12 11.76 MMP3 MMP1 CCL2
13 11.6 TIMP1 REN MMP9 MMP3 CCL2
Show member pathways
15 11.57 TIMP1 MMP9 CCL2
16 11.44 PLG MMP9 LPA APOB
17 11.34 TIMP1 PLG MMP9 MMP3 MMP1
18 11.24 THBD MMP9 MMP1 CCL2
19 11.17 MMP9 CCL2 APOE ACE
20 11.11 TIMP1 MMP9 CCL2
Show member pathways
22 11.05 PLG MMP9 ACE
23 10.95 TIMP1 MMP1 CCL2
24 10.94 SELE PLG MMP9 MMP3 MMP1

GO Terms for Carotid Artery Disease

Cellular components related to Carotid Artery Disease according to GeneCards Suite gene sharing:

(show all 11)
# Name GO ID Score Top Affiliating Genes
1 collagen-containing extracellular matrix GO:0062023 9.89 PLG MMP9 MMP8 APOE APOA1
2 extracellular region GO:0005576 9.83 TIMP1 REN PLG MMP9 MMP8 MMP3
3 extracellular matrix GO:0031012 9.73 TIMP1 MMP9 MMP8 MMP3 MMP1 APOE
4 high-density lipoprotein particle GO:0034364 9.63 APOE APOB APOA1
5 very-low-density lipoprotein particle GO:0034361 9.61 APOE APOB APOA1
6 endocytic vesicle lumen GO:0071682 9.58 APOE APOB APOA1
7 low-density lipoprotein particle GO:0034362 9.54 APOE APOB APOA1
8 chylomicron GO:0042627 9.5 APOE APOB APOA1
9 extracellular space GO:0005615 9.5 TIMP1 THBD SELE REN PLG MMP9
10 discoidal high-density lipoprotein particle GO:0034365 9.48 APOE APOA1
11 intermediate-density lipoprotein particle GO:0034363 9.33 APOE APOB APOA1

Biological processes related to Carotid Artery Disease according to GeneCards Suite gene sharing:

(show all 35)
# Name GO ID Score Top Affiliating Genes
1 extracellular matrix organization GO:0030198 9.95 MMP9 MMP8 MMP3 MMP1
2 cytokine-mediated signaling pathway GO:0019221 9.91 TIMP1 MMP9 MMP3 MMP1 CCL2
3 leukocyte migration GO:0050900 9.9 THBD SELE MMP1 APOB
4 response to lipopolysaccharide GO:0032496 9.88 THBD SELE REN APOB
5 receptor-mediated endocytosis GO:0006898 9.87 CD163 APOE APOB APOA1
6 proteolysis GO:0006508 9.86 REN PLG MMP9 MMP8 MMP3 MMP1
7 lipid transport GO:0006869 9.84 LPA APOE APOB APOA1
8 response to organic substance GO:0010033 9.83 TIMP1 REN APOB
9 retinoid metabolic process GO:0001523 9.78 APOE APOB APOA1
10 intermembrane lipid transfer GO:0120009 9.72 APOE APOB APOA1
11 amyloid-beta metabolic process GO:0050435 9.67 REN ACE
12 lipoprotein metabolic process GO:0042157 9.67 APOE APOB APOA1
13 negative regulation of blood coagulation GO:0030195 9.66 THBD APOE
14 high-density lipoprotein particle assembly GO:0034380 9.65 APOE APOA1
15 phospholipid efflux GO:0033700 9.65 APOE APOA1
16 cholesterol efflux GO:0033344 9.65 APOE APOB APOA1
17 angiotensin maturation GO:0002003 9.64 REN ACE
18 high-density lipoprotein particle clearance GO:0034384 9.64 APOE APOA1
19 negative regulation of fibrinolysis GO:0051918 9.63 THBD PLG
20 chylomicron remnant clearance GO:0034382 9.63 APOE APOB
21 low-density lipoprotein particle remodeling GO:0034374 9.63 LPA APOE APOB
22 cellular protein metabolic process GO:0044267 9.63 TIMP1 PLG MMP1 APOE APOB APOA1
23 very-low-density lipoprotein particle remodeling GO:0034372 9.62 APOE APOA1
24 positive regulation of cholesterol esterification GO:0010873 9.62 APOE APOA1
25 collagen catabolic process GO:0030574 9.62 MMP9 MMP8 MMP3 MMP1
26 negative regulation of platelet activation GO:0010544 9.61 THBD APOE
27 regulation of neuroinflammatory response GO:0150077 9.61 MMP9 MMP8 MMP3
28 regulation of Cdc42 protein signal transduction GO:0032489 9.59 APOE APOA1
29 very-low-density lipoprotein particle clearance GO:0034447 9.58 APOE APOB
30 chylomicron assembly GO:0034378 9.58 APOE APOB APOA1
31 lipoprotein catabolic process GO:0042159 9.56 APOE APOB
32 chylomicron remodeling GO:0034371 9.54 APOE APOB APOA1
33 positive regulation of phospholipid efflux GO:1902995 9.52 APOE APOA1
34 lipoprotein biosynthetic process GO:0042158 9.13 APOE APOB APOA1
35 extracellular matrix disassembly GO:0022617 9.1 TIMP1 PLG MMP9 MMP8 MMP3 MMP1

Molecular functions related to Carotid Artery Disease according to GeneCards Suite gene sharing:

(show all 13)
# Name GO ID Score Top Affiliating Genes
1 hydrolase activity GO:0016787 10.1 REN PLG MMP9 MMP8 MMP3 MMP1
2 zinc ion binding GO:0008270 10 TIMP1 MMP9 MMP8 MMP3 MMP1 ACE
3 signaling receptor binding GO:0005102 9.88 REN PLG CCL2 APOE APOA1
4 peptidase activity GO:0008233 9.76 REN PLG MMP9 MMP8 MMP3 MMP1
5 metalloendopeptidase activity GO:0004222 9.71 MMP9 MMP8 MMP3 MMP1
6 metallopeptidase activity GO:0008237 9.65 MMP9 MMP8 MMP3 MMP1 ACE
7 lipid transporter activity GO:0005319 9.61 APOE APOB APOA1
8 low-density lipoprotein particle receptor binding GO:0050750 9.54 CRP APOE APOB
9 lipoprotein particle binding GO:0071813 9.51 APOE APOA1
10 intermembrane cholesterol transfer activity GO:0120020 9.5 APOE APOB APOA1
11 phosphatidylcholine-sterol O-acyltransferase activator activity GO:0060228 9.46 APOE APOA1
12 serine-type endopeptidase activity GO:0004252 9.43 PLG MMP9 MMP8 MMP3 MMP1 LPA
13 endopeptidase activity GO:0004175 9.17 REN PLG MMP9 MMP8 MMP3 MMP1

Sources for Carotid Artery Disease

9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
31 HPO
32 ICD10
33 ICD10 via Orphanet
37 LifeMap
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
54 Novoseek
57 OMIM via Orphanet
61 PubMed
70 Tocris
72 UMLS via Orphanet
Loading form....